Affiliation: National Institutes of Health
- Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesionsL Wideroff
NCI ARB, EPN 313 MSC 7344, Bethesda, MD 20892 7344, USA
J Infect Dis 180:1424-8. 1999..These data suggest that seroreactivity to a given type reflects mainly type-specific HPV infection as measured by DNA detection and may also signal past exposure to other types that are now only serologically detected...
- A health services research agenda for cellular, molecular and genomic technologies in cancer careLouise Wideroff
National Cancer Institute, Bethesda, MD, USA
Public Health Genomics 12:233-44. 2009..In recent decades, extensive resources have been invested to develop cellular, molecular and genomic technologies with clinical applications that span the continuum of cancer care...
- Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physiciansL Wideroff
Applied Research Program Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892 7344, USA
J Med Genet 42:749-55. 2005....
- Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview SurveyLouise Wideroff
National Cancer Institute, Division of Cancer Control and Population Sciences, National Institutes of Health, Bethesda, MD 20892 7344, USA
Community Genet 6:147-56. 2003..This study explores factors associated with differential awareness of genetic tests for increased cancer risk in the US...
- Coherence and completeness of population-based family cancer reportsLouise Wideroff
National Cancer Institute, Bethesda, Maryland, USA
Cancer Epidemiol Biomarkers Prev 19:799-810. 2010..Given its widespread use in cancer screening and surveillance, better information is needed about the clarity and accuracy of family history information reported in the general population...
- Physician use of genetic testing for cancer susceptibility: results of a national surveyLouise Wideroff
National Cancer Institute, Division of Cancer Control and Population Sciences, Bethesda, Maryland 20892 7344, USA
Cancer Epidemiol Biomarkers Prev 12:295-303. 2003..39; 95% CI, 0.23-0.66%). These findings underscore the importance of establishing effective clinical approaches to test use and promoting physician education to facilitate communication with patients about cancer genetics...
- GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomasLouise Wideroff
Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, EPN 4005, 6130 Executive Boulevard, MSC 7344, Bethesda, MD 20892 7344, USA
Cancer Detect Prev 31:233-6. 2007..In a population-based case-control study, we examined risks in relation to polymorphisms of the following genes: GSTP1; GSTM1; GSTT1; NAT1; and CYP1A1...
- US physicians' attitudes toward genetic testing for cancer susceptibilityA N Freedman
Division of Cancer Control and Population Sciences, National Cancer Institute NIH, EPN 4005 MSC 7344, 6130 Executive Boulevard, Bethesda, MD 20892 7344, USA
Am J Med Genet A 120:63-71. 2003..Results of this national survey underscore the need to provide physicians with clear guidelines on the use of genetic cancer susceptibility tests and effective medical training on their appropriate implementation...
- Prevalence of family history of breast, colorectal, prostate, and lung cancer in a population-based studyP L Mai
Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20852, USA
Public Health Genomics 13:495-503. 2010..A positive family history is a known risk factor for several cancers; thus, obtaining a thorough family cancer history is essential in cancer risk evaluation and prevention management...
- Specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007K Robin Yabroff
National Cancer Institute and the National Institutes of Health, Bethesda, and Information Management Services, Silver Spring, Maryland, USA
Ann Intern Med 151:602-11. 2009..Little information is available about primary care physicians' current Papanicolaou (Pap) test screening practices, including initiation, frequency, and stopping...
- U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortalityMarie Josèphe Horner
Laboratory for Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 8717 Grovemont Circle, Gaithersburg, MD 20892, USA
Cancer Epidemiol Biomarkers Prev 20:591-9. 2011..To define priority areas for prevention efforts, we examined the geographic distribution of cervical cancer screening, incidence, stage, and mortality in the United States, prior to the introduction of HPV-based prevention technologies...
- Hypermethylation of GSTP1, CD44, and E-cadherin genes in prostate cancer among US Blacks and WhitesKaren Woodson
Cancer Prevention Studies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA
Prostate 55:199-205. 2003..Epigenetic events such as promoter-region gene hypermethylation may be influenced by environmental exposures and have been implicated in prostate carcinogenesis (by the silencing of tumor suppressors and other regulatory genes)...
- Population estimates of extended family structure and sizeAnne Garceau
Division of Cancer Control and Population Sciences, Risk Factor Monitoring and Methods Branch, National Cancer Institute, Bethesda, MD 20892, USA
Community Genet 11:331-42. 2008..Population-based estimates of biological family size can be useful for planning genetic studies, assessing how distributions of relatives affect disease associations with family history and estimating prevalence of potential family support...
- Physician exposure to and attitudes toward advertisements for genetic tests for inherited cancer susceptibilitySusan Thomas Vadaparampil
Health Outcomes and Behavior Program, H Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA
Am J Med Genet A 135:41-6. 2005..At that time, one-quarter of the physicians considered advertisements to play an important role in their clinical decision making, suggesting attention to other sources of information and additional factors...
- The impact of acculturation on awareness of genetic testing for increased cancer risk among Hispanics in the year 2000 National Health Interview SurveySusan T Vadaparampil
Health Outcomes and Behavior Program, H Lee Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine, Tampa, USA
Cancer Epidemiol Biomarkers Prev 15:618-23. 2006..These factors must be taken into account when informing individuals about the role of genetics in cancer risk and providing cancer genetic health services...
- Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort studyGustaf Edgren
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Lancet 369:1724-30. 2007..Our aim was to investigate the possible risk of cancer transmission from blood donors to recipients through blood transfusion...
- Cancer incidence in blood transfusion recipientsHenrik Hjalgrim
Department of Epidemiology Research, Statens Serum Institut, Artillerivej 5, DK 2300 Copenhagen South, Denmark
J Natl Cancer Inst 99:1864-74. 2007..Blood transfusions may influence the recipients' cancer risks both through transmission of biologic agents and by modulation of the immune system. However, cancer occurrence in transfusion recipients remains poorly characterized...
- Correlates of cervical mucosal antibodies to human papillomavirus 16: results from a case control studyCynthia Bierl
Viral Exanthems and Herpesvirus Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Gynecol Oncol 99:S262-8. 2005..In addition, standardization of mucosal sample collection and testing methods are required...
- Genetic test evaluation: information needs of clinicians, policy makers, and the publicWylie Burke
University of Washington, Seattle, WA, USA
Am J Epidemiol 156:311-8. 2002....